ALX Oncology Holdings Statistics
Total Valuation
ALXO has a market cap or net worth of $737.74 million. The enterprise value is $590.00 million.
| Market Cap | 737.74M |
| Enterprise Value | 590.00M |
Important Dates
The last earnings date was Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ALXO has 52.10 million shares outstanding. The number of shares has increased by 22.66% in one year.
| Shares Outstanding | 52.10M |
| Shares Change (YoY) | +22.66% |
| Shares Change (QoQ) | +2.16% |
| Owned by Insiders (%) | 2.03% |
| Owned by Institutions (%) | 94.02% |
| Float | 21.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 4.49 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.21, with a Debt / Equity ratio of 0.06.
| Current Ratio | 5.21 |
| Quick Ratio | n/a |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -102.55 |
Financial Efficiency
Return on equity (ROE) is -90.40% and return on invested capital (ROIC) is -101.12%.
| Return on Equity (ROE) | -90.40% |
| Return on Assets (ROA) | -72.20% |
| Return on Capital (ROIC) | -101.12% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.31M |
| Employee Count | 72 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +125.20% in the last 52 weeks. The beta is 1.30, so ALXO's price volatility has been higher than the market average.
| Beta (1Y) | 1.30 |
| 52-Week Price Change | +125.20% |
| 50-Day Moving Average | 13.87 |
| 200-Day Moving Average | 10.84 |
| Relative Strength Index (RSI) | 42.96 |
| Average Volume (30 Days) | 531,529 |
Short Selling Information
The latest short interest is 3.16 million, so 6.07% of the outstanding shares have been sold short.
| Short Interest | 3.16M |
| Short Previous Month | 3.69M |
| Short % of Shares Out | 6.07% |
| Short % of Float | 14.79% |
| Short Ratio (days to cover) | 5.17 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -175.84M |
| Pretax Income | -166.20M |
| Net Income | -166.20M |
| EBITDA | -163.76M |
| EBIT | -164.60M |
| Earnings Per Share (EPS) | -$3.71 |
Balance Sheet
The company has $157.44 million in cash and $9.70 million in debt, giving a net cash position of $147.73 million or $2.84 per share.
| Cash & Cash Equivalents | 157.44M |
| Total Debt | 9.70M |
| Net Cash | 147.73M |
| Net Cash Per Share | $2.84 |
| Equity / Book Value | 164.20M |
| Book Value Per Share | 3.15 |
| Working Capital | 135.64M |
Cash Flow
In the last 12 months, operating cash flow was -$140.47 million and capital expenditures -$732,000, giving a free cash flow of -$141.20 million.
| Operating Cash Flow | -140.47M |
| Capital Expenditures | -732,000 |
| Free Cash Flow | -141.20M |
| FCF Per Share | -$2.82 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ALXO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.66% |
| Shareholder Yield | -22.66% |
| Earnings Yield | -22.53% |
| FCF Yield | -19.14% |
Analyst Forecast
The average price target for ALXO is $19.67, which is 38.42% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.67 |
| Price Target Difference | 38.42% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |